Genpharmasec

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE861N01036
  • NSEID:
  • BSEID: 531592
INR
1.06
0.01 (0.95%)
BSENSE

Nov 20

BSE+NSE Vol: 3.57 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.06",
    "chg": 0.01,
    "chgp": "0.95%",
    "dir": 1,
    "prev_price": "1.05",
    "mcapval": "59.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE861N01036",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "3.57 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpharmasec Ltd Valuation Shifts to Fair Amidst Challenging Market Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/genpharmasec-ltd-valuation-shifts-to-fair-amidst-challenging-market-returns-4265834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GenpharmasecLtd_valuationdot_4265834.png",
        "date": "2026-11-18 08:01:25",
        "description": "Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid subdued financial performance and challenging sector dynamics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Genpharmasec Surges 11.11% in a Week: Key Financial and Valuation Shifts Drive Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/genpharmasec-surges-1111-in-a-week-key-financial-and-valuation-shifts-drive-momentum-4256074",
        "imagepath": "",
        "date": "2026-11-08 09:01:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens at Rs.1.02, up 3.03%</p>\n                    <p><strong>3 Nov:</strong> Continued gains with Rs.1.04 close (+1.96%)</p>\n                    <p><strong>4 Nov:</strong> Strong rally to Rs.1.09 (+4.81%) ahead of upgrades</p>\n                    <p><strong>5 Nov:</strong> Upgraded to Sell rating and valuation shift; stock closes at Rs.1.13 (+3.67%)</p>\n                    <p><strong>6 Nov:</strong> Minor correction to Rs.1.10 (-2.65%) despite Sensex rise</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.0.99</div></div>\n            ..."
      },
      {
        "title": "Genpharmasec Ltd Valuation Shifts Signal Changing Market Perception",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/genpharmasec-ltd-valuation-shifts-signal-changing-market-perception-4251180",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GenpharmasecLtd_valuationdot_4251180.png",
        "date": "2026-11-05 08:00:51",
        "description": "Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. This change, coupled with its recent price movements and peer comparisons, offers investors a fresh perspective on the stock’s price attractiveness amid a challenging market backdrop."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4225501",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/GenpharmasecLtd_mojoScore_4225501.png",
        "date": "2026-10-14 10:10:27",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4208517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GenpharmasecLtd_mojoScore_4208517.png",
        "date": "2026-09-29 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4196297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GenpharmasecLtd_mojoScore_4196297.png",
        "date": "2026-09-17 10:10:04",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 17 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4182466",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GenpharmasecLtd_mojoScore_4182466.png",
        "date": "2026-09-04 10:10:27",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a shift from a previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      }
    ],
    "total": 31,
    "sid": "329838",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Nov-2026",
      "details": "Newspaper Publication of Unaudited Financial Results for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th September 2026.",
      "datetime": "03-Nov-2026",
      "details": "Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "03-Nov-2026",
      "details": "Outcome of the Meeting of Board of Directors held on Tuesday 03rd November 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Nov-2026 | Source : BSE

Newspaper Publication of Unaudited Financial Results for the quarter and half year ended September 30 2026.

Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th September 2026.

03-Nov-2026 | Source : BSE

Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September 2026.

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

03-Nov-2026 | Source : BSE

Outcome of the Meeting of Board of Directors held on Tuesday 03rd November 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Genpharmasec Ltd has announced 1:10 stock split, ex-date: 11 Apr 19

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Genpharmasec Ltd has announced 1:1 rights issue, ex-date: 09 Jan 24